ArticleCancers2021

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy.

Hideya Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.